Patrick B. Johnston
About
Patrick B. Johnston is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics.
According to data from OpenAlex, Patrick B. Johnston has authored 300 papers receiving a total of 7.6k indexed citations (citations by other indexed papers that have themselves been cited), including 163 papers in Pathology and Forensic Medicine, 116 papers in Oncology and 89 papers in Genetics. Recurrent topics in Patrick B. Johnston's work include Lymphoma Diagnosis and Treatment (162 papers), Chronic Lymphocytic Leukemia Research (70 papers) and CAR-T cell therapy research (49 papers). Patrick B. Johnston is often cited by papers focused on Lymphoma Diagnosis and Treatment (162 papers), Chronic Lymphocytic Leukemia Research (70 papers) and CAR-T cell therapy research (49 papers). Patrick B. Johnston collaborates with scholars based in United States, United Kingdom and Switzerland. Patrick B. Johnston's co-authors include Ivana N. Micallef, David J. Inwards, Stephen M. Ansell, Luis F. Porrata, Thomas M. Habermann, Thomas E. Witzig, Joseph P. Colgan, Grzegorz S. Nowakowski, Svetomir N. Markovic and Benjamin Crost and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Journal of Neuroscience.
In The Last Decade
Patrick B. Johnston
283 papers receiving 7.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Patrick B. Johnston United States | 47 | 3.6k | 2.9k | 1.9k | 1.4k | 1.4k | 300 | 7.6k | ||
| Harald Holte Norway | 41 | 3.8k 1.0× | 3.2k 1.1× | 1.3k 0.7× | 971 0.7× | 698 0.5× | 248 | 6.5k | ||
| Barry W. Hancock United Kingdom | 44 | 3.1k 0.9× | 3.0k 1.0× | 753 0.4× | 1.1k 0.8× | 935 0.7× | 235 | 8.2k | ||
| Laurence Brugières France | 52 | 3.2k 0.9× | 3.1k 1.1× | 845 0.5× | 2.1k 1.6× | 2.9k 2.1× | 239 | 9.7k | ||
| John Radford United Kingdom | 65 | 8.8k 2.4× | 7.8k 2.7× | 3.0k 1.6× | 2.4k 1.7× | 1.6k 1.2× | 377 | 15.7k | ||
| Peter Borchmann Germany | 45 | 4.5k 1.3× | 3.5k 1.2× | 1.0k 0.6× | 1.5k 1.1× | 930 0.7× | 305 | 7.1k | ||
| Ann S. LaCasce United States | 45 | 5.0k 1.4× | 3.5k 1.2× | 2.3k 1.3× | 1.6k 1.2× | 1.2k 0.9× | 208 | 7.7k | ||
| John P. Leonard United States | 67 | 9.4k 2.6× | 6.7k 2.3× | 5.2k 2.8× | 1.6k 1.2× | 4.2k 3.1× | 490 | 17.1k | ||
| Craig H. Moskowitz United States | 56 | 10.4k 2.9× | 8.8k 3.0× | 3.2k 1.7× | 4.1k 3.0× | 1.3k 0.9× | 304 | 14.2k | ||
| Leslie Popplewell United States | 34 | 2.0k 0.6× | 2.8k 0.9× | 751 0.4× | 406 0.3× | 1.1k 0.8× | 202 | 5.0k | ||
| Ulrich Jaeger Austria | 41 | 2.8k 0.8× | 2.2k 0.7× | 2.1k 1.1× | 518 0.4× | 1.8k 1.3× | 210 | 7.0k |
Countries citing papers authored by Patrick B. Johnston
Since
Specialization
Citations
This map shows the geographic impact of Patrick B. Johnston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick B. Johnston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick B. Johnston more than expected).
Fields of papers citing papers by Patrick B. Johnston
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Patrick B. Johnston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick B. Johnston. The network helps show where Patrick B. Johnston may publish in the future.
Co-authorship network of co-authors of Patrick B. Johnston
This figure shows the co-authorship network connecting the top 25 collaborators of Patrick B. Johnston. A scholar is included among the top collaborators of Patrick B. Johnston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick B. Johnston. Patrick B. Johnston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Lillemoe, Keith D., Patrick B. Johnston, Yu‐Hui Chang, et al.. (2025). A 10-Year Real-world Assessment of Longitudinal Outcomes Following Bailout Procedures for Severe Cholecystitis. Annals of Surgery. 282(4). 553–562.
2.
Tun, Aung M., Yucai Wang, Seth Maliske, et al.. (2024). Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy. Haematologica. 109(7). 2186–2195.
3.
Bansal, Radhika, Hassan B. Alkhateeb, Stephen M. Ansell, et al.. (2024). Metformin and cytokine release syndrome after immune effector cell therapy.. Journal of Clinical Oncology. 42(16_suppl). e14535–e14535.
4.
Bansal, Radhika, Paschalis Vergidis, Pritish K. Tosh, et al.. (2024). Serial Evaluation of Preimmunization Antibody Titers in Lymphoma Patients Receiving Chimeric Antigen Receptor T Cell Therapy. Transplantation and Cellular Therapy. 30(4). 455.e1–455.e7.
5.
Porrata, Luis F., Stephen M. Ansell, Ivana N. Micallef, et al.. (2023). Day 100 Natural Killer Cell/CD14+HLA‐DRDIM ratio and survival in lymphoma post‐autologous peripheral blood hematopoietic stem cell transplantation. Clinical Transplantation. 38(1). e15211–e15211.
6.
Iyer, Swaminathan P., Patrick B. Johnston, & Stefan K. Barta. (2023). Pralatrexate injection combined with CHOP for treatment of PTCL: results from the Fol-CHOP dose-finding phase 1 trial. Blood Advances. 8(2). 353–364.
7.
Zhou, Jihao, Yucai Wang, Thomas M. Habermann, et al.. (2023). Incidence of Central Nervous System Relapse in Patients with Primary Mediastinal Large B-Cell Lymphoma: A Retrospective Study. Blood. 142(Supplement 1). 6279–6279.
8.
Strouse, Christopher, Melissa C. Larson, Shawna L. Ehlers, et al.. (2022). Long-Term Health-Related Quality of Life of Autologous Hematopoietic Cell Transplantation Patients and Nontransplant Patients With Aggressive Lymphoma: A Prospective Cohort Analysis. JCO Oncology Practice. 18(7). e1069–e1080.
9.
Abramson, Jeremy S., Scott R. Solomon, Jon Arnason, et al.. (2022). Improved Quality of Life (QOL) with Lisocabtagene Maraleucel (liso-cel), a CD19-Directed Chimeric Antigen Receptor T Cell Therapy, Compared with Standard of Care (SOC) Using Salvage Chemotherapy (CT) Followed By Autologous Stem Cell Transplantation (ASCT) As Second-Line (2L) Treatment in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Results from the Phase 3 Transform Study. Transplantation and Cellular Therapy. 28(3). S188–S189.
10.
Moustafa, Muhamad Alhaj, Liuyan Jiang, Madiha Iqbal, et al.. (2022). Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience. Clinical Lymphoma Myeloma & Leukemia. 22(8). e815–e825.
11.
Pederson, Levi, Betsy LaPlant, Raphael Mwangi, et al.. (2022). PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts. Blood Cancer Journal. 12(5). 78–78.
12.
Iqbal, Madiha, Jonas Paludo, Allison Rosenthal, et al.. (2021). Impact of Cell of Origin on Outcomes After Autologous Hematopoietic Cell Transplant in Diffuse Large B-Cell Lymphoma. Clinical Lymphoma Myeloma & Leukemia. 22(2). e89–e95.
13.
Khurana, Arushi, Abdullah S. Al Saleh, Tuan Truong, et al.. (2021). Response to Bridging Therapy (BT) before CAR-T Cell Infusion Predicts Outcomes for Relapsed/Refractory (R/R) Aggressive B-Cell Non-Hodgkin Lymphoma (NHL). Transplantation and Cellular Therapy. 27(3). S416–S417.
14.
Khurana, Arushi, Matthew Hathcock, Thomas M. Habermann, et al.. (2021). Lines of Therapy before Autologous Stem Cell Transplant (ASCT) and CAR-T Infusion Affect Outcomes in Aggressive Non-Hodgkin’s Lymphoma (NHL). Transplantation and Cellular Therapy. 27(3). S45–S47.
15.
Khurana, Arushi, Radhika Bansal, Matthew Hathcock, et al.. (2021). Polatuzumab Vedotin Use before Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Aggressive Lymphoma: A US Single Center Experience. Blood. 138(Supplement 1). 3842–3842.
16.
Khurana, Arushi, Matthew Hathcock, Radhika Bansal, et al.. (2021). Response to Bridging Therapy As a Predictor of Outcomes for Chimeric Antigen Receptor Therapy in Large B-Cell Lymphoma. Blood. 138(Supplement 1). 3841–3841.
17.
Kleinstern, Geffen, Matthew J. Maurer, Mark Liebow, et al.. (2018). History of autoimmune conditions and lymphoma prognosis. Blood Cancer Journal. 8(8). 73–73.
18.
Manheim, David, et al.. (2017). Are Terrorists Using Cryptocurrencies. Foreign Affairs.
19.
Witzig, Thomas E., Craig B. Reeder, Jing Han, et al.. (2015). The mTORC1 inhibitor everolimus has antitumor activity in vitro and produces tumor responses in patients with relapsed T-cell lymphoma. Blood. 126(3). 328–335.
20.
O’Neill, Brian Patrick, Mark E. Law, Paul A. Decker, et al.. (2008). Del(6)(q22) and BCL6 Rearrangements in Primary CNS Lymphoma Are Indicators of an Aggressive Clinical Course. Journal of Clinical Oncology. 26(29). 4814–4819.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Harald Holte Breakdown of academic impact, for papers by Barry W. Hancock Breakdown of academic impact, for papers by Laurence Brugières Breakdown of academic impact, for papers by John Radford Breakdown of academic impact, for papers by Peter Borchmann Breakdown of academic impact, for papers by Ann S. LaCasce Breakdown of academic impact, for papers by John P. Leonard Breakdown of academic impact, for papers by Craig H. Moskowitz Breakdown of academic impact, for papers by Leslie Popplewell Breakdown of academic impact, for papers by Ulrich Jaeger